Hypertrophic Cardiomyopathy
Advertisement
CardioNerds (Amit Goyal & Daniel Ambinder) join Brown University cardiology fellows (Greg Salber, Vrinda Trivedi, ...
The United States Food and Drug Administration (FDA) approved Mavacamten to treat patients with symptomatic obstructive ...
CardioNerds (Amit Goyal & Daniel Ambinder) join Virginia Commonwealth University (VCU) cardiology fellows (Ajay ...
Amit joins Dr. Laura Young to take a pulse check with these great experts.
Dr. Edward Kasper shares a unique historical perspective on how the field evolved as medicine learned more about HCM.
In this insightful interview, Rawan Amir, MBBS, and CardioNerds Academy Fellow, spoke with Milind Desai, MD, MBA, ...
As novel therapeutic agents such as Mavacamten and Tafamidis are developed and become clinically useful for patients ...
New pharmacological agent reduces need for septal reduction therapy in patients with symptomatic obstructive ...
Historically, early detection of hypertrophic cardiomyopathy (HCM) has been challenging, and prior artificial ...
Clinical and echo expert Dr. Jose Madrazo discusses a high yield and practical approach to diagnose HCM.
Dr. Fatimah Alkhunaizi and the CardioNerds discuss pathophysiology, diagnosis, imaging, and management of HCM.
CardioNerds Rounds Co-Chair, Dr. Karan Desai, joins Dr. Michelle Kittleson to discuss hypertrophic cardiomyopathy.
CardioNerds (Amit Goyal, Daniel Ambinder, Carine Hamo, and Karan Desai) are honored to bring to you the Braunwald ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.